Categories AlphaGraphs, Earnings, Health Care

Infographic: AngioDynamics reports adjusted loss for Q1 2024; sales down 4%

AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported a net loss, on an adjusted basis, for the first quarter of 2024 when its revenue declined. The medical device maker also reaffirmed its full-year guidance.

AngioDynamics Q1 2024 earnings infographic

Net loss, excluding special items, was $0.12 per share in the August quarter, compared to a loss of $0.06 per share in the same period of 2023. On an unadjusted basis, it was a profit of $45.9 million or $1.15 per share in Q1, compared to a loss of $13.0 million or $0.33 per share in the prior-year quarter.

First-quarter revenues decreased 4% year-over-year to $78.7 million. The company continues to expect fiscal 2024 revenues to be in the range of $328 million to $333 million.

Commenting on the results, AngioDynamics’ CEO Jim Clemmer said, “We remain focused on bringing innovative new products to market, expanding the approved indications for our existing products, and continuing to build a body of compelling clinical evidence in support of these indications and products.”

Prior Performance

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Important takeaways from Broadcom’s (AVGO) Q4 2023 earnings

Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) ended fiscal 2023 on a positive note, delivering strong results for the fourth quarter. In the new fiscal year, the company’s focus will be

Here’s what Signet Jewelers (SIG) expects for the holiday season and beyond

Shares of Signet Jewelers Limited (NYSE: SIG) were down over 2% on Friday. The stock has gained 40% year-to-date and 27% over the past three months. The jewelry retailer saw

DOCU Earnings: DocuSign Q3 2024 revenue up 9%; profit beats estimates

eSignature service provider DocuSign, Inc. (NASDAQ: DOCU) reported higher revenues and better-than-expected adjusted earnings for the third quarter of 2024. The company also provided guidance for the fourth quarter and

Add Comment
Viewing Highlight